share_log

NeuroBo Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(7.7%),Altium Growth Fund, LP EIN:(7.7%), etc.

NeuroBo Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Altium Capital Management, LP EIN:(7.7%),Altium Growth Fund, LP EIN:(7.7%)等

2022/11/17 17:08
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息